Pathkey.AI Ltd (PKY)

Pathkey.AI Ltd is a digital health company focused on leveraging artificial intelligence to transform clinical trial design and improve patient outcomes in Australia. The company develops advanced decision-support software, including its flagship platform TrialKey, which uses predictive analytics to optimize clinical trial protocols, forecast success probabilities, and recommend protocol adjustments that enhance efficiency and reduce costs. Pathkey.AI also offers TrialGen, an AI-powered tool that streamlines the clinical trial design process for pharmaceutical, medical device, and healthcare organizations. Drawing on a proprietary dataset of over 500,000 curated clinical trials and 1,500+ variables per trial, the company delivers actionable insights for biopharma, MedTech, government, and research clients. Pathkey.AI’s solutions are designed to accelerate the development of new therapies, strengthen research proposals, and support strategic decision-making across the life sciences sector. Headquartered in Milsons Point, Australia, the company operates as a specialist in health information services and application software, serving a global market with a focus on innovation in clinical research.